Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Evaluation of a Therapeutic Education Intervention Focused on the Accession of Patients Treated With Hormonal Therapy in the Management of Breast Cancer: PEPs Hormonotherapy

NCT02300675 is registered in ClinicalTrials.gov with Institut de Cancérologie de la Loire as lead sponsor.

NCT NCT02300675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02300675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Evaluation of a Therapeutic Education Intervention Focused on the Accession of Patients Treated With Hormonal Therapy in the Management of Breast Cancer: PEPs Hormonotherapy
Lead sponsor
Institut de Cancérologie de la Loire
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2014
Completion date
August 31, 2017
Enrollment
352 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer